Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2006-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Characterization of Macroprolactinemia
NCT00436111
Laboratory Diagnosis of of Rickettsial and Rickettsia-like Diseases
NCT01137175
Developing a Simple Recognition System of Acromegaly
NCT03042026
3D Single Cell Analysis Using Cell Morphology and Organelle Scattering Texture
NCT02335463
Exploring the Possibility to Use Glycosyltransferase as a Prognosis Marker of Neuroblastoma
NCT01638572
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
glucocorticoid-resistant patients
No interventions assigned to this group
2
glucocorticoid-sensitive patients
No interventions assigned to this group
3
normal controls
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Received drugs or drinks containing alcohol within one month
* Having symptom such as infection
* Supersensitivity and endocrine disturbance.
15 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Changhai Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of integrative medicien,Changhai Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jing Li, professor
Role: PRINCIPAL_INVESTIGATOR
Changhai Hospital
References
Explore related publications, articles, or registry entries linked to this study.
Du J, Li M, Zhang D, Zhu X, Zhang W, Gu W, Feng Y, Zhai X, Ling C. Flow cytometry analysis of glucocorticoid receptor expression and binding in steroid-sensitive and steroid-resistant patients with systemic lupus erythematosus. Arthritis Res Ther. 2009;11(4):R108. doi: 10.1186/ar2763. Epub 2009 Jul 14.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
30730114
Identifier Type: -
Identifier Source: secondary_id
061210
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.